Vanguard Group
ERAS icon

Vanguard Group’s Erasca ERAS Stock Holding History

Vanguard Group’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$47.7M Buy
12,812,156
+324
+0% +$911 ﹤0.01% 2185
2025
Q3 		$27.9M Buy
12,811,832
+116,235
+0.9% +$185K ﹤0.01% 2455
2025
Q2 		$16.1M Sell
12,695,597
-31,828
-0.3% -$42.6K ﹤0.01% 2654
2025
Q1 		$17.4M Buy
12,727,425
+53,525
+0.4% +$91.9K ﹤0.01% 2565
2024
Q4 		$31.8M Sell
12,673,900
-614,840
-5% -$1.69M ﹤0.01% 2358
2024
Q3 		$36.3M Buy
13,288,740
+2,936,994
+28% +$8.27M ﹤0.01% 2318
2024
Q2 		$24.4M Buy
10,351,746
+6,013,638
+139% +$13M ﹤0.01% 2465
2024
Q1 		$8.94M Buy
4,338,108
+545,765
+14% +$1.09M ﹤0.01% 3023
2023
Q4 		$8.08M Sell
3,792,343
-1,322,769
-26% -$2.79M ﹤0.01% 3069
2023
Q3 		$10.1M Sell
5,115,112
-1,508,119
-23% -$3.86M ﹤0.01% 2872
2023
Q2 		$18.3M Buy
6,623,231
+579,443
+10% +$1.65M ﹤0.01% 2629
2023
Q1 		$18.2M Buy
6,043,788
+218,234
+4% +$794K ﹤0.01% 2629
2022
Q4 		$25.1M Buy
5,825,554
+224,462
+4% +$1.52M ﹤0.01% 2518
2022
Q3 		$43.7M Buy
5,601,092
+575,333
+11% +$4.63M ﹤0.01% 2246
2022
Q2 		$28M Buy
5,025,759
+98,895
+2% +$647K ﹤0.01% 2477
2022
Q1 		$42.4M Buy
4,926,864
+3,299,572
+203% +$38.2M ﹤0.01% 2385
2021
Q4 		$25.4M Sell
1,627,292
-399,479
-20% -$6.84M ﹤0.01% 2716
2021
Q3 		$43M Buy
+2,026,771
New +$41.8M ﹤0.01% 2442

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Vanguard Group's ERAS Position: Q4 2025 in Review

Vanguard Group increased its Erasca (ERAS) stake by 0% in Q4 2025, buying an estimated $911 and bringing the position to 12,812,156 shares worth $47.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2185.

Vanguard Group first reported a position in ERAS in Q3 2021 and has held it in 18 quarters since. 154 funds tracked by Wall St. Rank hold ERAS as of Q4 2025.

  • Vanguard Group held 12,812,156 shares of Erasca worth $47.7M as of Q4 2025.
  • Vanguard Group bought 324 Erasca shares in Q4 2025, an estimated $911.
  • Erasca made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2185 holding.
  • Vanguard Group first reported a position in Erasca in Q3 2021 and has held it in 18 quarters since.
  • 154 funds tracked by Wall St. Rank held Erasca as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.